Researchers use genetics to develop cancer meds from bacteria

07/9/2013 | Business Weekly (U.K.)

Researchers at the University of East Anglia are working on new cancer treatments that address a fundamental cause of chemotherapy resistance. The research centers on a type of antibiotic produced by Streptomyces bacteria, which live symbiotically with leaf cutter ants. "We're using genetics to understand how the drugs are made in the bacteria so we can tweak the characteristics in favor of anti-cancer action, whilst protecting healthy cells," lead researcher Matt Hutchings said. "We want to make Streptomyces into a factory to produce a new type of chemotherapy drug on a large scale."

View Full Article in:

Business Weekly (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA